Quick Answer: Founder vesting in an Israeli startup is almost always structured as reverse vesting: founders receive all their shares upfront, but the company holds a contractual right to repurchase unvested shares at nominal value (NIS 0.01 per share) if a founder departs early. The standard schedule is four years with a one-year cliff. There is no statutory vesting law in Israel; the mechanism lives entirely in your shareholders' agreement and articles of association. Getting the drafting right from day one prevents extremely costly disputes when a co-founder leaves or the company is acquired.

Israel has more Nasdaq-listed companies per capita than any country outside the United States, and its venture capital market attracts billions in foreign investment every year. For foreign co-founders, diaspora entrepreneurs returning to Israel, or international investors taking early stakes in Israeli companies, the mechanics of founder equity can be disorienting. Israeli practice closely mirrors Silicon Valley norms, but it sits on top of the Hok HaHavarot (Companies Law 5759-1999) rather than US corporate statutes, and those differences matter in practice.

What follows covers how reverse vesting is structured under Israeli law, what the standard schedule looks like, how to handle exits and early departures, what holding IIA grants means for your deal, and the key tax rules for both Israeli-resident and foreign founders.

1. What Is Founder Vesting?

Vesting ties a founder's entitlement to their equity stake to continued involvement over time. Without it, a co-founder could walk away on day two and still own 40% of the business for life. That's a problem for the remaining founders and a red flag for every investor who looks at the cap table.

It serves two purposes. First, it aligns incentives: you build value by staying, and you keep equity in proportion to your actual contribution. Second, most institutional VCs and angel investors in Israel will not invest in a company where founders hold fully vested shares from day one with no clawback. Vesting is often a hard condition of closing a funding round, not a negotiable point.

In the US, vesting is often implemented through option grants to founders. In Israel, the near-universal approach is reverse vesting of ordinary shares: the founders own the shares immediately, but the company acquires the right to buy them back if a founder leaves before they fully vest.

In Practice: When an Israeli startup is formed, founders typically subscribe for ordinary shares at a nominal price of NIS 0.01 per share (the par value under most standard articles of association). The total consideration paid is often just NIS 1–100 for a founder's entire stake — for example, NIS 0.01 × 1,000,000 shares = NIS 10,000. The Registrar of Companies (part of the Israel Corporations Authority within the Ministry of Justice) requires a Form Gimmel (Form G) to be filed within 30 days of share allotment, recording the new shareholders. Failing to file can prevent a future share transfer from being recognized.

2. How Reverse Vesting Works Under Israeli Law

Israeli company law contains no dedicated vesting statute. The Companies Law 5759-1999 governs how shares are issued and transferred, but vesting schedules are a creature of contract. They live across three inter-related documents:

  • Shareholders' Agreement (*Heskem Baalei Manim*): the primary contractual instrument. It defines the vesting schedule, the repurchase right, the price on repurchase, and the good leaver/bad leaver distinction.
  • Articles of Association (*Takanonim*): the company's constitutional document filed with the Registrar of Companies. To give the repurchase right a corporate-law foundation rather than just a personal contractual obligation, transfer restrictions and the repurchase mechanism should be incorporated into the articles.
  • Founders' Agreement (*Heskem Meyasdim*): sometimes a separate document from the shareholders' agreement, covering IP assignment, non-compete obligations, and vesting conditions during the pre-incorporation phase.

The mechanics work like this: the shareholders' agreement grants the company (or the other founders, depending on drafting) a call option over the founder's unvested shares. The option is exercisable at the original subscription price, typically NIS 0.01 per share, for a short window of 60 to 90 days after a founder's departure. If the company does not exercise within that window, the right lapses and the departing founder retains those shares. Good drafting closes the window automatically on departure rather than requiring a separate exercise notice, which is easy to miss.

In Practice: Under Section 293 of the Companies Law 5759-1999, a company may issue shares subject to restrictions on transfer, and Section 291 permits companies to buy back their own shares subject to solvency requirements (the company must pass the "earnings test" and "solvency test"). For a reverse vesting repurchase to work as a true buyback — rather than a transfer to other shareholders — the company needs retained earnings or distributable profits. Many seed-stage startups have no profits, so the repurchase right is often structured as a transfer to a trustee or the other founders rather than a company buyback, which avoids the Section 291 constraint.

3. The Standard Vesting Schedule in Israeli Startups

The Israeli startup market has largely converged on the same schedule used in Silicon Valley:

  • Total period: 48 months (4 years)
  • Cliff: 12 months — no shares vest during the first year. If a founder leaves before the cliff, all shares are subject to repurchase at NIS 0.01.
  • Post-cliff vesting: After 12 months, 25% of the total shares vest immediately. The remaining 75% vest monthly in equal instalments over the following 36 months (approximately 2.08% per month).

Some companies use quarterly vesting post-cliff, which is administratively simpler, or a front-loaded schedule (30%/year 2, 25%/year 3, 20%/year 4) to reflect the disproportionate value of early contributions. However, any deviation from the 4/1 standard tends to raise questions from VCs who are accustomed to it.

The start date of the vesting schedule is usually tied to the company's incorporation date or the date the founders' agreement is signed. If co-founders have already been working together for six months before incorporation, they often negotiate backdated vesting credit — for example, starting the vesting clock six months before the company was formally registered, so they receive partial credit for the pre-company period. This needs careful documentation because investors will scrutinize it during due diligence.

In Practice — Typical Israeli Seed-Stage Cap Table: A two-founder startup incorporated in Israel with 1,000,000 shares might look like this: Founder A: 500,000 shares (50%), Founder B: 500,000 shares (50%), both subject to 4-year/1-year cliff reverse vesting. At month 12, each founder vests 125,000 shares (25%). At month 48, all shares are fully vested. If Founder B leaves at month 18, the company can repurchase 500,000 × (30/48) = 312,500 unvested shares at NIS 0.01 each — a total repurchase price of NIS 3,125 regardless of the company's current valuation.
Advertisement

4. Accelerated Vesting on Exit or M&A

What happens to unvested shares when the company is acquired? The answer carries multi-million shekel consequences and is one of the most fought-over clauses in any Israeli founders' agreement.

Single-trigger acceleration means all unvested shares vest automatically upon a "change of control" event, typically defined as a sale of more than 50% of the company's shares, a merger, or a sale of all or substantially all assets. The founder walks away with 100% of their equity regardless of how long they served.

Double-trigger acceleration requires two things: a change of control AND a subsequent termination without cause (or resignation for good reason) within a defined window, typically 12 to 18 months after closing. Acquirers strongly prefer this because it preserves the founder's incentive to stay through integration.

Israeli VCs and strategic acquirers push for double-trigger. Founders push for at least partial single-trigger. The compromise seen most often in Israeli deals: 50% vests on the change of control alone, 100% if the second trigger fires within 12 months of closing.

Acceleration provisions need precise drafting. What counts as a "change of control"? Does an IIA-subsidized asset sale require Ministry approval before acceleration rights can be exercised? Is a public offering a change of control? These are not hypothetical questions. All three have produced disputes in real Israeli exit transactions.

In Practice — M&A Timing: Israeli M&A transactions typically close 60–120 days after a letter of intent is signed, during which time founders may continue vesting. This "gap period" adds up: a 90-day gap translates to roughly 6.25% additional vesting on a standard schedule, worth meaningful equity in a high-value deal. Founders should track their vesting date precisely and negotiate that the effective date of any acceleration clause is the signing of the definitive agreement, not the later closing, to avoid disputes over the gap period.

5. Good Leaver / Bad Leaver Provisions Under Israeli Law

Israeli shareholders' agreements classify departures as "good leaver" or "bad leaver" because the category determines the repurchase price, and that price is the difference between walking away with something and walking away with NIS 0.01 per share regardless of what the company is worth.

Bad Leaver: A founder who leaves under circumstances defined as "bad" loses unvested shares at the original subscription price (NIS 0.01 per share, effectively zero in most cases). Common bad-leaver triggers include:

  • Termination for cause (gross misconduct, fraud, theft, breach of fiduciary duty)
  • Voluntary resignation to join a direct competitor during the non-compete period
  • Material breach of the founders' agreement or IP assignment obligations
  • Criminal conviction involving moral turpitude

Good Leaver: A founder who leaves through no fault of their own — death, permanent disability, or termination without cause after the cliff date — is treated more generously. Unvested shares are typically repurchased at fair market value as determined by an agreed valuation mechanism (often an independent accountant or the company's most recent 409A-equivalent valuation). Vested shares are retained in full.

Some Israeli agreements add a third category — "Permitted Resignation" — for situations like moving abroad for family reasons or pursuing further education, where the leaver is not entirely "good" (they're leaving voluntarily) but the circumstances are sympathetic. The repurchase price here might be fair market value for unvested shares, but at a 20–30% discount.

In Practice: Israeli courts (specifically the Tel Aviv District Court — Economic Department (*Beit Mishpat Mehozi — Merkaz Inyanim Kalkaliyim*)) have enforced good leaver/bad leaver provisions but have occasionally intervened where the repurchase price at NIS 0.01 appears grossly disproportionate to the company's actual value, treating it as a penalty clause (*kenosit*) rather than genuine liquidated damages. To reduce the risk of judicial modification, the shareholders' agreement should contain an express recital that the parties acknowledge the repurchase price reflects the uncertainty of the company's value at formation (not a penalty) and was freely negotiated with legal advice.

6. IIA Grant Holders: Special Rules That Affect Vesting

The Israel Innovation Authority (IIA), formerly known as the Office of the Chief Scientist, is Israel's main technology grant body. Many Israeli startups receive R&D grants under the Law for the Encouragement of Research, Development and Technological Innovation in Industry (R&D Law), 5744-1984. Those grants come with obligations that reach directly into how equity events are structured.

Under Section 19 of the R&D Law, a "transfer of know-how," which the IIA interprets broadly to include asset sales and certain company acquisitions, requires the IIA's prior written approval. That approval process takes 45 to 120 days and may require payment of royalties or a lump-sum fee based on the grant amount received.

In a full acquisition, the acquirer's obligation to honour accelerated vesting of founders' shares is conditional on IIA approval. If the deal structure requires the company's IP to move (asset sale, IP assignment to the acquirer's holding entity), the IIA must sign off before shares vest. Founders who negotiate strong single-trigger acceleration without accounting for IIA timelines may find their acceleration rights technically triggered but practically unenforceable until the regulator clears the deal.

In Practice — IIA Fees on Exit: The royalty obligation under the R&D Law is calculated on cumulative revenues until the full grant amount plus interest is repaid. For M&A transactions, the IIA may instead require a lump-sum payment typically equal to the outstanding grant balance multiplied by a factor of 1 to 3 depending on whether the acquirer is Israeli or foreign. A deal where a U.S. company acquires an Israeli startup that received NIS 2,000,000 in IIA grants would typically require a payment of NIS 2,000,000 to NIS 6,000,000 to the IIA at closing. Founders and investors need to model this as a deal cost that reduces net proceeds, and therefore the value of vested shares at exit.

7. Tax Treatment of Founder Shares in Israel

Two variables drive the tax analysis: whether the founder receives shares directly or options, and whether they are an Israeli tax resident or not.

Shares received directly at nominal value (the typical founder reverse vesting structure):

  • If shares are issued at true fair market value at the time of issuance, there is generally no taxable income event at that moment. For a startup with no revenue and uncertain prospects, the Israel Tax Authority (ITA) typically accepts that fair market value equals par value (NIS 0.01).
  • When the founder eventually sells vested shares, the gain is subject to capital gains tax under Section 91 of the Income Tax Ordinance [New Version] 5721-1961. For Israeli residents: 25% on real gain (or 30% if the seller held more than 10% of the company). For non-residents: the same 25% rate applies, subject to applicable double-taxation treaties — Israel's treaty network includes the US, UK, Germany, France, the Netherlands, and most EU countries.

Options granted to founders (less common but occasionally used):

  • Options fall under Section 102 of the Income Tax Ordinance, which provides two tracks for equity compensation through a trustee. Under the Capital Gains Track (preferred for founders and investors), options held for at least 24 months from grant date are taxed at the flat 25% capital gains rate on the full gain — no income tax on the spread.
  • The company must file an approved stock option plan with the ITA and appoint an approved trustee. The trustee holds the shares or options until the end of the required holding period.

Foreign founders — practical note: A non-resident founder who holds ordinary shares in an Israeli company is not subject to Israeli tax until a taxable event occurs (sale, dividend). However, if the founder provides services to the company in Israel, those services may create a taxable employment or self-employment income event separately from the shares. The ITA has increased scrutiny of arrangements where a foreign resident provides services to an Israeli company in exchange for shares at nominal value when the company already has significant embedded value.

In Practice — 83(b) Equivalent in Israel: Unlike the United States, Israel has no direct equivalent to the IRS Section 83(b) election, which lets a US founder include the value of unvested shares in income at grant (when they're worth almost nothing) rather than at vesting (when they may be worth a lot). Israeli law does not require founders to recognize income on unvested shares, because the reverse vesting repurchase right means the founder's legal ownership of unvested shares is conditional. For US citizens holding Israeli founder shares, consult a cross-border tax specialist: the IRS may assert that the shares are "substantially vested" (and therefore includible in income) at a time different from what Israeli law provides.

8. What to Include in Your Founders' Agreement

Israeli founders' agreements vary in length and complexity, but there are nine provisions that need to be there from the start:

  • Vesting schedule and start date — total period, cliff length, vesting frequency, and the precise start date (incorporation, signing, or backdated to commencement of work)
  • Repurchase mechanism — who holds the repurchase right (company, other founders, or a trustee), the exercise period (60–90 days after departure), and the price (par value for bad leavers, fair market value for good leavers)
  • Good leaver / bad leaver definitions — precise, exhaustive lists of triggering events for each category; avoid catch-all language that creates ambiguity
  • Accelerated vesting provisions — single-trigger vs. double-trigger, definition of change of control, treatment of IPO, and interaction with IIA requirements
  • IP assignment clause — mandatory for IIA-backed companies. All founders must assign to the company any pre-existing IP related to the business. The assignment should be drafted before grant applications are filed.
  • Non-compete and non-solicit — Israeli courts have narrowed the enforceability of non-compete clauses significantly (particularly post-Checkpoint v. Cytec, Supreme Court 2014). The clause should be geographically limited, time-limited (6–12 months is more defensible than 24), and tied to a specific field of activity.
  • Tag-along and drag-along rights — protects minority founders if majority shareholders sell, and ensures the majority can close a deal even if a minority founder is uncooperative
  • Right of first refusal (ROFR) — each founder must offer shares to the other founders before selling to a third party
  • Dispute resolution — specify whether disputes go to the Israeli courts (Economic Department, Tel Aviv District Court) or to arbitration under the Israeli Arbitration Law 5728-1968, and the governing law (Israeli law is almost always chosen for Israeli company disputes)

The founders' agreement should be signed simultaneously with (or before) the company's formal incorporation. Agreements signed after shares are issued without vesting are far harder to enforce because the shares are already fully owned.

In Practice — Timeline and Costs: Drafting a comprehensive founders' agreement in Israel typically takes 2–4 weeks with legal counsel and costs NIS 5,000–NIS 25,000 depending on complexity. The agreement must be reviewed by the Israel Corporations Authority (part of the Ministry of Justice) if it contains articles changes that require filing. Amendments to articles of association (*takanonim*) require a shareholder resolution (ordinary majority for most changes, special majority — 75% — for entrenched provisions), filing of Form Shin-6 (Amendment to Articles) within 30 days, and payment of the registration fee (currently approximately NIS 400 per filing as of 2026). Any share allotment under the vesting schedule must also be reported via Form Gimel within 30 days of the allotment date.